Thiocolchicine

更新时间:2024-01-02 16:30:40

Thiocolchicine结构式
Thiocolchicine结构式
品牌特惠专场
常用名 Thiocolchicine 英文名 Thiocolchicine
CAS号 2730-71-4 分子量 415.50300
密度 1.27g/cm3 沸点 729.1ºC at 760mmHg
分子式 C22H25NO5S 熔点 N/A
MSDS 中文版 美版 闪点 394.7ºC
符号 GHS05 GHS06 GHS08
GHS05, GHS06, GHS08
信号词 Danger

 Thiocolchicine用途

tip
本网站展示的所有产品仅用作科学研究,不可食用,不可用于人体或动物的临床诊断和治疗。

Thiocolchicine 是秋水仙碱 (HY-16569) 的衍生物,是一种有效的微管蛋白聚合 (tubulin polymerization) 抑制剂(IC50=2.5 µM),其 Ki 值为 0.7 µM 竞争性结合微管蛋白。Thiocolchicine 可以作为 ADC 的毒素分子。

 Thiocolchicine名称

中文名 硫代秋水仙碱
英文名 N-[(7S)-1,2,3-trimethoxy-10-methylsulfanyl-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide
英文别名 更多

 Thiocolchicine生物活性

描述 Thiocolchicine 是秋水仙碱 (HY-16569) 的衍生物,是一种有效的微管蛋白聚合 (tubulin polymerization) 抑制剂(IC50=2.5 µM),其 Ki 值为 0.7 µM 竞争性结合微管蛋白。Thiocolchicine 可以作为 ADC 的毒素分子。
相关类别
体外研究 硫秋水仙碱对MCF-7、LoVo、LoVo/DX、A-549和BALB/3T3细胞的IC50值分别为0.01μM、0.021μM、0.398μM、0.011μM和0.114μM[3]。硫秋水仙碱(1nm-100μM;24-72小时)显示细胞周期阻滞活性与乳腺癌细胞生长抑制之间的关系。它抑制MDA-MB-231和多药耐药(MDR)MCF-7 ADRr乳腺癌细胞的增殖,IC50s分别为0.6nm和400nm,以及MDR CEM-VBL白血病细胞(IC50=50nm)[2]。
参考文献

[1]. Klaus M.Hahn, et al. Structural requirements for the binding of colchicine analogs to tubulin: the role of the C-10 substituent. Bioorganic & Medicinal Chemistry Letters.Volume 1, Issue 9, 1991, Pages 471-476

[2]. R De Vincenzo, et al. Antiproliferative Activity of Colchicine Analogues on MDR-positive and MDR-negative Human Cancer Cell Lines. Anticancer Drug Des. 1998 Jan;13(1):19-33.

 Thiocolchicine物理化学性质

密度 1.27g/cm3
沸点 729.1ºC at 760mmHg
分子式 C22H25NO5S
分子量 415.50300
闪点 394.7ºC
精确质量 415.14500
PSA 99.16000
LogP 3.97580
外观性状 固体
蒸汽压 4.12E-21mmHg at 25°C
折射率 1.609
储存条件 2-8°C,密封,干燥

 Thiocolchicine毒性和生态

 Thiocolchicine安全信息

符号 GHS05 GHS06 GHS08
GHS05, GHS06, GHS08
信号词 Danger
危害声明 H300 + H330-H318-H340
警示性声明 P201-P260-P264-P280-P284-P301 + P310
危害码 (欧洲) T+
危险品运输编码 UN 1544PSN1 6.1 / PGI

 Thiocolchicine文献23

更多文献
Antiproliferative activity of colchicine analogues on MDR-positive and MDR-negative human cancer cell lines.

Anticancer Drug Des. 13 , 19-33, (1998)

In this study the in vitro antitumor activity of a series of 20 colchicine analogues was tested and compared with colchicine and thiocolchicine on three different human cancer cell lines, two of which...

Antitumor agents--CLXXV. Anti-tubulin action of (+)-thiocolchicine prepared by partial synthesis.

Bioorg. Med. Chem. 5(12) , 2277-82, (1997)

(+)-Thiocolchicine (2b) was prepared from (+/-)-colchicine (1) in a five-step reaction sequence that included chromatographic separation of appropriate camphanylated diastereomers. Acid hydrolysis of ...

Thiocolchicine dimers: a novel class of topoisomerase-I inhibitors.

Biochem. Pharmacol. 69(1) , 113-21, (2005)

During a cellular screening of thiocolchicine analogs, thiocolchicine dimers resulted particularly active in cisplatin-resistant A2780-CIS cells. In order to discover by which mechanism(s) thiocolchic...

 Thiocolchicine英文别名

thiocolhicine
N-[(7S)-1,2,3-trimethoxy-10-methylsulfanyl-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl]acetamide
10-Demethoxy-10-methylthiocolchicine
N-((S)-1,2,3-trimethoxy-10-methylsulfanyl-9-oxo-5,6,7,9-tetrahydro-benzo[a]heptalen-7-yl)-acetamide
Thiocolchicine
thiocolchicine
EINECS 220-346-8
Colchicine,10-thio
N-((S)-1,2,3-Trimethoxy-10-methylmercapto-9-oxo-5,6,7,9-tetrahydro-benzo[a]heptalen-7-yl)-acetamid
Thiocholchicine
Colchicine,10-demethoxy-10-(methylthio)